Big blow to Moderna vaccine projects as Trump cancels over $700 million funding

The Trump administration has slashed $766 million allocated in funding to Moderna Inc., an American biotech and pharmaceutical company responsible for developing vaccines. Moderna was tasked to make vaccines against potential pandemic influenza viruses, as well as the H5N1 bird flu. This comes at a time when a new Covid strain has sparked concerns in the US.